Immunohistochemical localization of c-erbB-2 protein and epidermal growth factor receptor in normal surface epithelium, surface inclusion cysts, and common epithelial tumours of the ovary

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Virchows Archiv

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/BF01606911PMID 1360720
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Expression of c-erbB-2 protein and epidermal growth factor receptor in normal tissues of the female genital tract and in the placenta

  2005cited by this paper
• Histological Typing of Ovarian Tumours.

  2000cited by this paper
• p185c-neu and epidermal growth factor receptor associate into a structure composed of activated kinases.

  1992cited by this paper
• Epidermal growth factor receptors (EGFR) in human ovarian cancer.

  1991cited by this paper
• Epithelial ovarian cancer: a cytokine propelled disease?

  1991cited by this paper
• Epidermal growth factor receptor expression in normal ovarian epithelium and ovarian cancer. I. Correlation of receptor expression with prognostic factors in patients with ovarian cancer.

  1991cited by this paper
• An immunohistochemical study of the incidence and significance of C-erbB-2 oncoprotein overexpression in ovarian neoplasia

  1991cited by this paper
• 504 Immunohistochemical localization of c-erbB-2 protein and epidermal growth factor receptor in normal tissues of the female genital tract and the placenta.

  1991cited by this paper
• Epidermal growth factor receptor expression in normal ovarian epithelium and ovarian cancer. II. Relationship between receptor expression and response to epidermal growth factor

  1991cited by this paper
• Inverse relationship of epidermal growth factor receptor and HER2/neu gene expression in human renal cell carcinoma.

  1990cited by this paper
• Increased erbB-2 gene copies and expression in multiple stages of breast cancer.

  1990cited by this paper
• Expression of the HER-2/neu proto-oncogene in normal human adult and fetal tissues.

  1990cited by this paper
• c‐erbB‐2 oncogene expression in ovarian cancer

  1990cited by this paper
• Direct interaction of a ligand for the erbB2 oncogene product with the EGF receptor and p185erbB2.

  1990cited by this paper
• Overexpression of HER-2/neu is associated with poor survival in advanced epithelial ovarian cancer.

  1990cited by this paper
• Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer.

  1989cited by this paper
• Distribution of neu (c-erbB-2) protein in human skin.

  1989cited by this paper
• C-erbB-2 gene product, a membrane protein commonly expressed on human fetal epithelial cells.

  1989cited by this paper
• Occurrence of epidermal growth factor receptors in human adnexal tumors and their prognostic value in advanced ovarian carcinomas.

  1988influential reference
• Embryology of the Female Genital Tract

  1987cited by this paper
• Expression of epidermal growth factor receptors on human cervical, ovarian, and vulval carcinomas.

  1986cited by this paper
• Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptor

  1986cited by this paper
• Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene.

  1985cited by this paper
• Histological Typing of Ovarian Tumours. International Histology Classification of Tumours, S.F. Serov, R.E. Scully. World Health Organization, Geneva (1973), 56, Slides: £21.00, US$51.00, Book only: £6.65, US$16.50

  1975cited by this paper

• EGFR and HER2 Expression in Primary Ovarian High-Grade Serous Carcinoma and Their Prognostic Value

  2020cites this paper
• Molecular Pathogenesis of Ovarian Cancer: An Inextricable Maze

  2018cites this paper
• Histological and immunohistochemical evaluation of granulosa cells during different stages of folliculogenesis in bovine ovaries

  2018cites this paper
• The immunoexpression of EGFR, HER2 and HER3 in malignant serous ovarian tumors.

  2017cites this paper
• Developmental Therapeutics for Gynecologic Cancers: An Overview

  2016cites this paper
• Hoxa 5 : A Key Player in Development and Disease

  2016cites this paper
• Hoxa5: A Key Player in Development and Disease

  2016cites this paper
• Evaluation of epidermal growth factor receptor in odontogenic tumors and rare soft tissue tumors by immunohistochemical and fluorescence in situ hybridization methods

  2016cites this paper
• Part 2 : Distribution of HER 2 / neu overexpression and gene amplification by organ , tumor site and histology

  2014cites this paper
• HER2/neu: an increasingly important therapeutic target. Part 2: Distribution of HER2/neu overexpression and gene amplification by organ, tumor site and histology

  2014cites this paper
• Targeting HER2 in ovarian and uterine cancers: challenges and future directions.

  2014cites this paper
• Comprehensive Profiling of EGFR/HER Receptors for Personalized Treatment of Gynecologic Cancers

  2014cites this paper
• HER2 Expression Beyond Breast Cancer: Therapeutic Implications for Gynecologic Malignancies

  2013cites this paper
• Network Analysis Identifies an HSP90-Central Hub Susceptible in Ovarian Cancer

  2013cites this paper
• EGFR, HER2/neu and Ki67 immunoexpression in serous ovarian tumors

  2012cites this paper
• EGFR, HER2÷neu and Ki67 immunoexpression in serous ovarian tumors.

  2012cites this paper
• Epidermal Growth Factor Receptor–Mediated Membrane Type 1 Matrix Metalloproteinase Endocytosis Regulates the Transition between Invasive versus Expansive Growth of Ovarian Carcinoma Cells in Three-Dimensional Collagen

  2009cites this paper
• Female Genital Tract

  2009cites this paper
• Risk Factors for Ovarian Cancer: An Overview with Emphasis on Hormonal Factors

  2008cites this paper
• Clinical implications of the ErbB/epidermal growth factor (EGF) receptor family and its ligands in ovarian cancer.

  2008cites this paper
• Histomorphological and immunohistochemical characterization of equine granulosa cell tumours.

  2007cites this paper
• Loss of ovarian function and the risk of ovarian cancer

  2005cites this paper
• c-myc Oncogene product P62C-rYc in ovarian mucinous neoplasms: immunohistochemical study correlated with malignancy

  2005cites this paper
• Immunohistochemical characterization of undifferentiated carcinomas of the ovary

  2005cites this paper
• Concentrations of Alpha-Fetoprotein, Insulin-Like Growth Factor Binding Protein-3, c-erbB-2, and Epidermal Growth Factor in Serum of Patients With Endometriosis

  2004cites this paper
• Her-2/neu expression and amplification in early stage ovarian surface epithelial neoplasms.

  2004cites this paper
• Immunohistochemical analysis of p53 protein and 72 kDa heat shock protein (HSP72) expression in ovarian carcinomas

  2004cites this paper
• CHAPTER 36 – Ovarian Carcinogenesis

  2004cites this paper
• A monoclonal antibody recognizing human cancers with amplification/overexpression of the human epidermal growth factor receptor

  2003cites this paper
• Tissue microarrays in drug discovery

  2003cites this paper
• c-erbB-2, p53, and nm23 proteins as prognostic factors in patients with epithelial ovarian carcinoma.

  2003cites this paper
• Proteins as Prognostic Factors in Patients with Epithelial Ovarian Carcinoma Snje

  2003cites this paper
• Clinical and molecular comparison between borderline serous ovarian tumors and advanced serous papillary ovarian carcinomas.

  2001cites this paper
• Human ovarian surface epithelial (OSE) cells express LH/hCG receptors, and HCG inhibits apoptosis of OSE cells via up‐regulation of insulin‐like growth factor‐1

  2001cites this paper
• Occult Carcinoma in Prophylactic Oophorectomy Specimens: Prevalence and Association With BRCA Germline Mutation Status

  2001cites this paper
• Expression and Action of Transforming Growth Factor Alpha in Normal Ovarian Surface Epithelium and Ovarian Cancer1

  2000cites this paper
• AN IMMUNOHISTOCHEMICAL STUDY OF THE RETE OVARII AND EPOOPHORON

  2000cites this paper
• Histopathologic features of ovaries at increased risk for carcinoma. A case-control analysis.

  1999cites this paper
• Coexpression of the HER-2 Gene Product, pl85HER-2, and Epidermal Growth Factor Receptor, pl70EGF-R, on Epithelial Ovarian Cancers and Normal Tissues

  1998cites this paper
• Amplification and expression of the c-erbB-2 oncogene in Müllerian-derived genital-tract tumors.

  1998cites this paper
• Epidermal Growth Factor Receptor and c-erbB-2 Oncoproteins in Tissue and Tumor Effusion Cells of Histopathologically Different Ovarian Neoplasms

  1998cites this paper
• Molecular approaches to diagnosis and management of ovarian cancer

  1997cites this paper
• Immunohistochemical assessment of proliferation markers and altered gene expression in archival specimens of ovarian epithelial tumors.

  1997cites this paper
• Ovarian intraepithelial neoplasia and ovarian cancer.

  1996cites this paper
• Quantitative analyses of epidermal growth factor receptors, HER‐2/neu oncoprotein and cathepsin D in nonmalignant and malignant uteri

  1996cites this paper
• Immunohistochemical study of c-erb B-2 protein expression in endometriosis.

  1995cites this paper
• Potential criteria for cohort selection in chemoprevention trials of epithelial ovarian cancer

  1995cites this paper
• Overexpression of c‐erbB‐2 in epithelial ovarian cancer. Prognostic value and relationship with response to chemotherapy

  1995cites this paper
• Frequent immunohistochemical detection of EGF supergene family members in ovarian carcinogenesis.

  1994cites this paper
• Immunohistochemical investigation of epidermal growth factor receptor expression in ameloblastomas

  1994cites this paper
• Epidermal Growth Factor Enhances Secretion of the Ovarian Tumor-Associated Cancer Antigen CAI25 From the Human Amnion WISH Cell Line

  1994cites this paper
• Expression of metastasis-related nm23-H1 and nm23-H2 genes in ovarian carcinomas: correlation with clinicopathology, EGFR, c-erbB-2, and c-erbB-3 genes, and sex steroid receptor expression.

  1994cites this paper
• Relationship between p53 and c-erbB-2 overexpression in tissue sections and cyst fluid cells of patients with ovarian cancer.

  1994cites this paper
• Expression of c‐erbb‐2 protein and epidermal growth factor receptor in endometrial carcinomas correlation with clinicopathologic and sex steroid receptor status

  1993cites this paper